Table 1 Trends in relative survival (%) by sex, time since diagnosis and calendar period of diagnosis: England and Wales, adults (15–99 years) diagnosed during 1986–1999 and followed up to 2001

From: Survival from non-Hodgkin lymphoma in England and Wales up to 2001

  

Calendar period of diagnosis a

    
  

1986–1990

1991–1995

1996–1999

Average change (%) every 5 years b

Prediction c for patients diagnosed during 2000–2001

Time since diagnosis

 

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

1 year

 Men

66.0

(65.1, 66.8)

66.9

(66.1, 67.6)

69.5

(68.7, 70.3)

2.2**

(0.6, 3.8)

70.0

(68.9, 71.2)

 

 Women

65.8

(64.9, 66.8)

67.5

(66.6, 68.3)

69.9

(69.0, 70.7)

2.4**

(0.7, 4.1)

70.9

(69.7, 72.1)

5 year

 Men

45.8

(44.8, 46.9)

47.0

(46.1, 47.9)

51.3

(50.2, 52.4)

4.0**

(2.0, 5.9)

52.6

(51.2, 54.0)

 

 Women

46.2

(45.1, 47.2)

49.1

(48.1, 50.0)

52.7

(51.5, 53.9)

3.6**

(1.4, 5.8)

53.9

(52.4, 55.3)

10 year

 Men

38.0

(36.9, 39.1)

39.4

(38.3, 40.5)

  

3.5

(−0.4, 7.3)

44.7

(43.1, 46.2)

 

 Women

36.2

(35.1, 37.3)

40.3

(39.1, 41.5)

  

8.7**

(4.5, 12.9)

43.8

(42.1, 45.4)

  1. CI=confidence interval.
  2. aSurvival estimated with cohort or complete approach (see Rachet et al, 2008).
  3. bMean absolute change (%) in survival every 5 years, adjusted for deprivation (see Rachet et al, 2008).
  4. cSurvival estimated with hybrid approach (see Rachet et al, 2008).
  5. **P<0.01.
Back to article page